Quick Answer
BIOADAPTIVES, INC. reported Operating Income of -$602.1 thousand for fiscal year 2024.
BIOADAPTIVES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$602.1K | -163.0% |
| 2023 | -$228.9K | +45.7% |
| 2022 | -$421.9K | -85.6% |
| 2015 | -$227.3K | +90.7% |
| 2014 | -$2.44M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$265.7K | -117.9% | +4.8% |
| June 30, 2025 | -$279.2K | -200.3% | -12.1% |
| March 31, 2025 | -$249.1K | -400.0% | -104.3% |
| September 30, 2024 | -$121.9K | -32.2% | -31.2% |
| June 30, 2024 | -$93.0K | -66.2% | -86.6% |
| March 31, 2024 | -$49.8K | -162.6% | +46.0% |
| September 30, 2023 | -$92.2K | — | -64.8% |
| June 30, 2023 | -$55.9K | — | -194.9% |
- BIOADAPTIVES, INC. showed a decrease of -163.0% in Operating Income compared to the prior fiscal year.
- Over the 2014–2024 period, BIOADAPTIVES, INC.’s operating income has grown by 75.3% (from -$2.44 million to -$602.1 thousand).
- The most recent figure is from BIOADAPTIVES, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: